Thyroscope and TORC partner on thyroid eye disease research

Resumen detallado
Thyroscope and TORC announced a strategic collaboration on 17 November 2026 combining smartphone monitoring and quantitative orbital imaging to support a longitudinal study and research database.
SEOUL, South Korea, Nov. 17, 2026 /PRNewswire/ -- Thyroscope (THYROSCOPE INC.) and The Orbital Radiology Center (TORC) today announced a memorandum of understanding to investigate an integrated approach to monitoring thyroid eye disease (TED) using smartphone-based artificial intelligence, quantitative orbital imaging and longitudinal clinical data.
Thyroscope will contribute its Glandy smartphone-based AI platform for monitoring patients between clinical visits, while TORC will provide quantitative orbital imaging expertise. Together, the partners will develop a multimodal TED research database integrating smartphone-based assessments, quantitative imaging and longitudinal clinical data. BioSight Innovations, also led by TORC CEO Dr. Shoaib Ugradar, will provide treatment sites, clinical assessments and longitudinal follow-up for the initial study.
TORC has provided contracted imaging assessment services for four clinical trials sponsored by Viridian Therapeutics, Zenas BioPharma, Lassen Therapeutics and Immunovant, and for an Amgen post-marketing study. Its scientific work includes nine published papers on quantitative imaging in TED.
TED is an autoimmune disease that can cause inflammation, proptosis, eyelid retraction, double vision and, in severe cases, irreversible vision loss. Despite expanding treatments, assessment still relies on scheduled clinic visits. Measurements such as proptosis and the Clinical Activity Score (CAS) may vary between assessors and do not fully capture changes within orbital tissues.
The partners will study whether home measurements and imaging improve longitudinal assessment.
Thyroscope's Glandy TED suite uses smartphone images and patient-reported information to assess inflammatory activity (Glandy CAS), proptosis (Glandy EXO) and eyelid morphology (Glandy LID). Its clinician-facing Glandoc platform makes patient-generated information available for review between appointments.
TORC analyzes orbital CT and MRI, clinical photographs and…
BioS…
Inicio del artículo, extracto de Vietnam Investment Review. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (vir.com.vn)




